Posttransplant erythrocytosis: a possible nonerythropoietin-mediated mechanism.
Morrone
L F
LF
Institute of Nephrology, University of Bari, Polyclinic, Italy.
Schena
A
A
Di Paolo
S
S
Stallone
G
G
Schena
F P
FP
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D004656:Enalapril / Q000627:therapeutic use; D004920:Erythropoiesis; D004921:Erythropoietin / Q000097:blood*; D005260:Female; D006400:Hematocrit; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D011086:Polycythemia / Q000097:blood / Q000209:etiology*; D011183:Postoperative Complications; D012016:Reference Values
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D004921:Erythropoietin; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; D004656:Enalapril